Route/evidence mismatch: the pivotal mouse study tested subcutaneous injection at a fixed research dose (20 mg/kg, three times daily) the oral capsule use that is actually sold and discussed commercially has not itself been directly tested in that published research
Success with AOD-9604 therapy requires comprehensive physician supervision, accurate dosing and reconstitution techniques, strategic timing to maximize lipolytic effects, objective monitoring of body composition changes, and integration with proper nutrition and exercise foundations
In these studies, the amount of 5-amino-1MQ administered was 10-20 mg/kg per day, allowing for precise measurement of its effect
Whether 5-Amino-1MQ, a GLP-1, or a combination fits you depends on your labs, your current medications, and your goals exactly the kind of call a provider makes with you, not a website